Charles Boustany said...

The bill has it as one percent of adjusted, but we want to make it revenue neutral.

This legislation provides an accelerated route to FDA approval and subsequent limited coverage under Medicare.

U.S. business is under assault, and U.S. business needs tax relief.

We should not penalize people for using those.